Advertisement
  • Seasonal Shot Strategies

    Researchers find that patients with cancer who are severely immunocompromised may benefit from a more frequent seasonal vaccine schedule.

    by Sandra Gordon

  • October 20: The Week in Cancer News

    Immunotherapy drug approved as pre- and post-surgery treatment for non-small cell lung cancer, and bladder cancer patients who respond to chemotherapy and immunotherapy can forgo surgery.

    by Thomas Celona

  • Increasing Diversity in Clinical Trials

    Researchers share approaches for improving participation among underrepresented groups at AACR conference.

    by Thomas Celona

  • Planning for the Return Home After Surgery

    Experts suggest patients prepare for home recovery before surgery to help maintain some control.

    by Coeli Carr

  • October 13: The Week in Cancer News

    Rising prevalence of non-melanoma skin cancer leads to more deaths across the globe, and siblings of cancer patients struggle to ask for help.

    by Eric Fitzsimmons

  • Making Treatment Decisions

    It’s not always clear what to do when cancer progresses. Abigail Johnston shares how she has approached treatment decisions since her metastatic breast cancer diagnosis in 2017.

    by Abigail M. Johnston

  • October 6: The Week in Cancer News

    Minority groups less likely to receive palliative care, and radiation oncology meeting focuses on shorter radiation courses.

    by Marci A. Landsmann

  • Fixing Systems, Building Trust

    The AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved explores efforts needed to address inequities in care and outcomes.

    by Eric Fitzsimmons

  • Accelerating and Improving Drug Discovery

    Forum for patient advocates explores how researchers are working to develop cancer treatments in a quicker, more efficient manner.

    by Thomas Celona

  • September 29: The Week in Cancer News

    Cancer drug shortages affect pediatric care, and ‘power dynamics’ limit women’s access to cancer care globally.

    by Kevin McLaughlin